Technologies, which will provide to those suffering from AIDS a cure for little or no cost!

Dr. Antelman has developed Tetrasil (r) (tetrasilver tetroxide) which is a patented bioinorganic antipathogenic molecular crystal device. Tetrasil kills pathogens by electrocuting them! Dr. Antelman, whose work throughout the years has varied from innovative designs for nuclear submarine reactors and smart card batteries, discovered that silver (Ag) actually is formed by Ag and Ag3, and it is this discovery that lead him to the development of Tetrasil. (Tetrasil is not colloidal silver.) Through the construction of a molecular sized semiconductor, Dr. Antelman was able to force natural silver (which is actually ag2) into its two separate components of Ag and Ag3 and to keep them separate, thus retaining the potential for an electron discharge. In layman's terms, one section of the Tetrasil machine contains an extra electron charge that desparately wantsto cross to the other side, but cannot due to the manner in which the molecular machine is constructed. The molecular machine is, thereby, polarized and charged, and remains so until triggered. The Tetrasil machine is triggered when it comes into contact with a pathogen (thus the reason for the name "anti-pathogenic molecular crystal device"). Pathogens (bacteria and virii alike) are drawn to the device by strong covalent forces, and when they come into contact with the machine they are locked into place by these forces. The extra electron charge is then free to make its way to the other side of the Tetrasil machine by traversing the cellular membrane of the pathogen, which it immediately does. The 2 volt discharge electrocutes the pathogen in the process. A chelation process is triggered as a result and both the Tetrasil machine and the dead pathogen bound to it are removed by the liver. The liver is stressed, but not damaged.

Tetrasil is classed as an EPA Class IV substance - the SAFEST rating available, which means it is safe for human consumption. EPA Class IV status is equivalent to FDA Stage One approval.

Tetrasil has redefined the standards by which the govt. judges efficacy against e-coli: nothing works faster and more effectively than Tetrasil.

In human clinical AIDS trials, a SINGLE IV injection of Tetrasil cured 8 of 10 terminal AIDS patients, who showed no sign of disease one year after treatment. The two other patients succumbed due to the damange already inflicted by the disease. It was too late for them.

Tetrasil will be distributed:

- as a cure for FAIDS (feline AIDS - 30% of all cats suffer from

the disease) in the USA, for which FDA approval is not needed.

- as spray disinfectants and wipes

- as treatment for drinking water and waste water (no poisonous

chlorine needed any longer)

- as disinfectant for cooling towers (no more legionaires disease)

- AS A CURE FOR HUMAN AIDS

- and many other uses

Dr. Antelman turned down millions of dollars from an NIH associated

group that wanted all rights to Tetrasil because he knew they would

make the treatment too costly or suppress it altogether.

(Dr. Antelman knows how the system works and is disgusted by it.)

Tetrasil has the potential to cure practically all disease caused

by pathogens, from TB, to the common cold. Dr. Antelman, an

orthodox rabbi, is a righteous man, who seeks to help ease human

suffering, not profit from it. (Rabbi Marvin S. Antelman is

a member of The Supreme Rabbinic Court, aka 'the Sanhedrin',

the oldest established court in the world.)

The Foundation for Incurable Diseases needs public support to

bring this modern miracle to the people of the world.

The pharmaceutical industry is already rallying to stonewall

distribution of Tetrasil, because it will replace all their

poisonous (and highly profitable) treatments for AIDS -- all of

which will kill a healthy person. Help us fight the true killers

-- the pharmaceutical industry. More people die from treatment for

AIDS than from the disease itself. The time has come to cease this

nonsense.

No one need ever die of AIDS again.

For information, please write to the above address, or e-mail

eellinwood@aol.com

redheifer@juno.com

Edwin Ellinwood

FID Public Relations